BofA raised the firm’s price target on Adient (ADNT) to $20 from $17.50 and keeps an Underperform rating on the shares. The firm raised its target due to progress on costs and potential business gains from production shift into the U.S. post tariffs, the analyst tells investors in a note post Q2 and production estimate revisions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT: